Clinical Trial Update: Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p [Phase 2, Phase 3]

View source ↗

Summary

A multi-center Phase 2/3 trial is evaluating the Venus-p percutaneous pulmonary valve implantation, for patients with pulmonary regurgitation and Tetralogy of F…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Regurgitation
• Tetralogy of Fallot

Drugs mentioned

• Venus-p

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Pulmonary Regurgitation, Tetralogy of Fallot | Phase 2, Phase 3 | Status: UNKNOWN